4,4'-methylenediphenol
- 1 lab in 1 country
- Model organisms1
Outcomes
6Lipofuscin
downin worms1
1 study
Lipofuscin
downin worms1
4,4'-methylenediphenol decreases lipofuscin in worms.
“4,4'-methylenediphenol treatment also reduced the contents of reactive oxygen species (ROS) and lipofuscin, and decreased Aβ protein deposition in the worms.”
Model organismsAlzheimer's disease model worms
Frontiers in aging neuroscience30 May 2024
DAF-16 nuclear translocation
upin worms1
1 study
DAF-16 nuclear translocation
upin worms1
4,4'-methylenediphenol increases daf-16 nuclear translocation in worms.
“4,4'-methylenediphenol promoted the nuclear translocation of DAF-16”
Model organismsGFP reporter worms
Frontiers in aging neuroscience30 May 2024
Aβ protein deposition
downin worms1
1 study
Aβ protein deposition
downin worms1
4,4'-methylenediphenol decreases Aβ protein deposition in worms.
“4,4'-methylenediphenol treatment also reduced the contents of reactive oxygen species (ROS) and lipofuscin, and decreased Aβ protein deposition in the worms.”
Model organismsAlzheimer's disease model worms
Frontiers in aging neuroscience30 May 2024
Reactive oxygen species
downin worms1
1 study
Reactive oxygen species
downin worms1
4,4'-methylenediphenol decreases reactive oxygen species in worms.
“4,4'-methylenediphenol treatment also reduced the contents of reactive oxygen species (ROS) and lipofuscin, and decreased Aβ protein deposition in the worms.”
Model organismsAlzheimer's disease model worms
Frontiers in aging neuroscience30 May 2024
Motility
upin worms1
1 study
Motility
upin worms1
4,4'-methylenediphenol improves motility in worms.
“4,4'-Methylenediphenol not only delayed paralysis onset and senescence in the AD model worms but also enhanced their motility and stress tolerance.”
Model organismsAlzheimer's disease model worms
Frontiers in aging neuroscience30 May 2024
Paralysis onset
downin worms1
1 study
Paralysis onset
downin worms1
4,4'-methylenediphenol decreases paralysis onset in worms.
“4,4'-Methylenediphenol not only delayed paralysis onset and senescence in the AD model worms but also enhanced their motility and stress tolerance.”
Model organismsAlzheimer's disease model worms
Frontiers in aging neuroscience30 May 2024